Marinela A.
- Country
- Germany
- Department
- Oncology and/or Hematology
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Phase 3 Study of Vepugratinib and Combination Therapy in Adults with Untreated FGFR3-Altered Locally Advanced or Metastatic Urothelial Carcinoma
- Phase II Trial of BMS-986365 Switch in Metastatic Castration-Sensitive Prostate Cancer with Suboptimal PSA Response after ADT and ARPI
Data & Insights
Has run more than one trial at 145 of 367 partner sites.
Specializations
Multiple Myeloma Research
This investigator specializes in advancing treatments for multiple myeloma, with particular emphasis on managing relapsed and refractory cases. Their research encompasses innovative therapeutic approaches including CAR T-cell therapy and novel drug combinations.
- Novel Treatment Combinations
- Maintenance Therapy Optimization
- Drug Administration Methods
Solid Tumor Studies
The investigator conducts research in treating various advanced solid tumors, focusing on innovative therapeutic approaches including bispecific T-cell engaging receptor molecules and targeted therapies for specific mutations.
- KRAS Mutation Targeted Therapy
- Immunotherapy Combinations
- Gastrointestinal Cancers
Hematologic Malignancies
The investigator's expertise extends to various blood cancers, including acute leukemias and myelofibrosis. Their research focuses on developing new therapeutic strategies and improving treatment outcomes.
- Leukemia Treatment Innovation
- Myelofibrosis Management
- Novel Drug Development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.